Eastern Asia: Vaccine Market 2024

Vaccine Market Size in Eastern Asia

The East Asian vaccine market expanded remarkably to $X in 2022, picking up by 7.9% against the previous year. Over the period under review, consumption posted a resilient expansion. The level of consumption peaked at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Vaccine Production in Eastern Asia

In value terms, vaccine production expanded rapidly to $X in 2022 estimated in export price. Over the period under review, production enjoyed a buoyant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 38%. Over the period under review, production hit record highs at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Vaccine Exports

Exports in Eastern Asia

In 2022, after four years of growth, there was significant decline in shipments abroad of vaccines for human medicine, when their volume decreased by -26.7% to X tons. Overall, exports, however, continue to indicate a resilient expansion. The growth pace was the most rapid in 2021 when exports increased by 88% against the previous year. As a result, the exports reached the peak of X tons, and then shrank remarkably in the following year.

In value terms, vaccine exports contracted rapidly to $X in 2022. In general, exports, however, saw resilient growth. The pace of growth was the most pronounced in 2021 when exports increased by 78% against the previous year. As a result, the exports reached the peak of $X, and then plummeted in the following year.

Exports by Country

In 2022, South Korea (X tons) represented the main exporter of vaccines for human medicine, mixing up 61% of total exports. China (X tons) held a 22% share (based on physical terms) of total exports, which put it in second place, followed by Japan (11%). Taiwan (Chinese) (X tons) and Hong Kong SAR (X tons) followed a long way behind the leaders.

From 2012 to 2022, average annual rates of growth with regard to vaccine exports from South Korea stood at +4.4%. At the same time, Taiwan (Chinese) (+56.2%), China (+18.1%), Hong Kong SAR (+13.8%) and Japan (+12.9%) displayed positive paces of growth. Moreover, Taiwan (Chinese) emerged as the fastest-growing exporter exported in Eastern Asia, with a CAGR of +56.2% from 2012-2022. While the share of China (+13 p.p.), Taiwan (Chinese) (+4.3 p.p.) and Japan (+4.1 p.p.) increased significantly in terms of the total exports from 2012-2022, the share of South Korea (-22.2 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest vaccine supplying countries in Eastern Asia were South Korea ($X), China ($X) and Japan ($X), together comprising 88% of total exports. Taiwan (Chinese) and Hong Kong SAR lagged somewhat behind, together comprising a further 12%.

Among the main exporting countries, Taiwan (Chinese), with a CAGR of +50.6%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Eastern Asia stood at $X per ton in 2022, growing by 6.6% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +3.4%. The most prominent rate of growth was recorded in 2019 when the export price increased by 16%. Over the period under review, the export prices attained the peak figure in 2022 and is expected to retain growth in the immediate term.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Taiwan (Chinese) ($X per ton), while South Korea ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+7.7%), while the other leaders experienced more modest paces of growth.

Vaccine Imports

Imports in Eastern Asia

In 2022, approx. X tons of vaccines for human medicine were imported in Eastern Asia; approximately mirroring the previous year. Overall, imports enjoyed a strong increase. The growth pace was the most rapid in 2019 when imports increased by 76% against the previous year. The volume of import peaked at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, vaccine imports shrank slightly to $X in 2022. In general, imports posted resilient growth. The pace of growth was the most pronounced in 2019 when imports increased by 117%. Over the period under review, imports hit record highs at $X in 2021, and then contracted slightly in the following year.

Imports by Country

In 2022, China (X tons) represented the largest importer of vaccines for human medicine, creating 62% of total imports. It was distantly followed by Japan (X tons), South Korea (X tons) and Taiwan (Chinese) (X tons), together making up a 34% share of total imports. Hong Kong SAR (X tons) held a relatively small share of total imports.

China was also the fastest-growing in terms of the vaccines for human medicine imports, with a CAGR of +14.7% from 2012 to 2022. At the same time, Taiwan (Chinese) (+9.2%) and Hong Kong SAR (+3.7%) displayed positive paces of growth. By contrast, Japan (-2.1%) and South Korea (-2.5%) illustrated a downward trend over the same period. China (+33 p.p.) and Taiwan (Chinese) (+2 p.p.) significantly strengthened its position in terms of the total imports, while South Korea and Japan saw its share reduced by -14.4% and -18.8% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) constitutes the largest market for imported vaccines for human medicine in Eastern Asia, comprising 71% of total imports. The second position in the ranking was held by Japan ($X), with an 11% share of total imports. It was followed by South Korea, with an 8.2% share.

In China, vaccine imports increased at an average annual rate of +32.4% over the period from 2012-2022. In the other countries, the average annual rates were as follows: Japan (-2.1% per year) and South Korea (+1.8% per year).

Import Prices by Country

The import price in Eastern Asia stood at $X per ton in 2022, with a decrease of -2.3% against the previous year. In general, the import price, however, enjoyed a strong expansion. The growth pace was the most rapid in 2016 when the import price increased by 26% against the previous year. Over the period under review, import prices hit record highs at $X per ton in 2021, and then contracted modestly in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was China ($X per ton), while Taiwan (Chinese) ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+15.4%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :